Teva- Pharmaceutical Industries Ltd

NYSE: TEVA
$13.01
+$0.13 (+1.0%)
Closing price April 23, 2024
Teva Pharmaceutical Industries Ltd is a global leader in the pharmaceutical industry, specializing in the development, manufacture, and distribution of generic and specialty medicines, as well as biopharmaceutical products. With a strong presence in North America, Europe, Israel, and beyond, Teva offers a wide range of medications, including treatments for central nervous system disorders, respiratory conditions, and cancer. The company is also known for its contributions to neurodegenerative and movement disorder treatments, with notable products like COPAXONE for multiple sclerosis and AJOVY for migraine prevention. Founded in 1901 and headquartered in Tel Aviv, Israel, Teva is committed to improving health and making quality healthcare accessible worldwide.
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
The December 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
The November 29 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Tuesday's top analyst upgrades, downgrades and initiations included Albermarle, Amgen, Applied Materials, Biogen, CRISPR Therapeutics, CrowdStrike, CSX, Kroger, Slack, Teva Pharmaceutical and Xerox.
The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
The October 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
The September 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Five drugmakers are considering a proposal that would have them contribute to a trust established as part of the bankruptcy settlement by Purdue Pharmaceuticals and be released from liability in the...
Monday's top analyst upgrades, downgrades and initiations included Apple, Bed Bath & Beyond, Chico's FAS, Clorox, Deere, Gap, Newell Brands, RealReal, Teva Pharmaceutical, UnitedHealth and Wells...
The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
The August 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
Johnson & Johnson is trading higher on the news, but some smaller public companies tied into the opioid crisis are taking it on the chin.
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.